Clearance of the Janus Kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia

Guillermo J. Ruiz-Argüelles, Javier Garcés-Eisele, Virginia Reyes-Núñez, Guillermo J. Ruiz-Delgado, Carlos Rosillo, John K Camoriano

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

A patient with myelofibrosis with myeloid metaplasia displaying the V617F mutation of the JAK2 gene was given an allogeneic stem cell transplantation using a reduced-intensity conditioning regimen. The patient engrafted, and as he became a chimera, the expression of the V617F mutation of the JAK2 gene decreased progressively until its disappearance. Accordingly, the concept of "molecular remission" of the myelofibrosis with myeloid metaplasia could be entertained and added to the categories of response to treatment which have been recently described.

Original languageEnglish (US)
Pages (from-to)400-402
Number of pages3
JournalAmerican Journal of Hematology
Volume82
Issue number5
DOIs
StatePublished - May 2007

Fingerprint

Janus Kinase 2
Primary Myelofibrosis
Stem Cell Transplantation
Mutation
Genes
Therapeutics

Keywords

  • Bone marrow transplantation
  • JAK2 V617F mutation
  • Molecular remission
  • Myelofibrosis with myeloid metaplasia

ASJC Scopus subject areas

  • Hematology

Cite this

Clearance of the Janus Kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia. / Ruiz-Argüelles, Guillermo J.; Garcés-Eisele, Javier; Reyes-Núñez, Virginia; Ruiz-Delgado, Guillermo J.; Rosillo, Carlos; Camoriano, John K.

In: American Journal of Hematology, Vol. 82, No. 5, 05.2007, p. 400-402.

Research output: Contribution to journalArticle

Ruiz-Argüelles, Guillermo J. ; Garcés-Eisele, Javier ; Reyes-Núñez, Virginia ; Ruiz-Delgado, Guillermo J. ; Rosillo, Carlos ; Camoriano, John K. / Clearance of the Janus Kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia. In: American Journal of Hematology. 2007 ; Vol. 82, No. 5. pp. 400-402.
@article{59bb3afc046c4fd8a832ea04809fe157,
title = "Clearance of the Janus Kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia",
abstract = "A patient with myelofibrosis with myeloid metaplasia displaying the V617F mutation of the JAK2 gene was given an allogeneic stem cell transplantation using a reduced-intensity conditioning regimen. The patient engrafted, and as he became a chimera, the expression of the V617F mutation of the JAK2 gene decreased progressively until its disappearance. Accordingly, the concept of {"}molecular remission{"} of the myelofibrosis with myeloid metaplasia could be entertained and added to the categories of response to treatment which have been recently described.",
keywords = "Bone marrow transplantation, JAK2 V617F mutation, Molecular remission, Myelofibrosis with myeloid metaplasia",
author = "Ruiz-Arg{\"u}elles, {Guillermo J.} and Javier Garc{\'e}s-Eisele and Virginia Reyes-N{\'u}{\~n}ez and Ruiz-Delgado, {Guillermo J.} and Carlos Rosillo and Camoriano, {John K}",
year = "2007",
month = "5",
doi = "10.1002/ajh.20832",
language = "English (US)",
volume = "82",
pages = "400--402",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Clearance of the Janus Kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia

AU - Ruiz-Argüelles, Guillermo J.

AU - Garcés-Eisele, Javier

AU - Reyes-Núñez, Virginia

AU - Ruiz-Delgado, Guillermo J.

AU - Rosillo, Carlos

AU - Camoriano, John K

PY - 2007/5

Y1 - 2007/5

N2 - A patient with myelofibrosis with myeloid metaplasia displaying the V617F mutation of the JAK2 gene was given an allogeneic stem cell transplantation using a reduced-intensity conditioning regimen. The patient engrafted, and as he became a chimera, the expression of the V617F mutation of the JAK2 gene decreased progressively until its disappearance. Accordingly, the concept of "molecular remission" of the myelofibrosis with myeloid metaplasia could be entertained and added to the categories of response to treatment which have been recently described.

AB - A patient with myelofibrosis with myeloid metaplasia displaying the V617F mutation of the JAK2 gene was given an allogeneic stem cell transplantation using a reduced-intensity conditioning regimen. The patient engrafted, and as he became a chimera, the expression of the V617F mutation of the JAK2 gene decreased progressively until its disappearance. Accordingly, the concept of "molecular remission" of the myelofibrosis with myeloid metaplasia could be entertained and added to the categories of response to treatment which have been recently described.

KW - Bone marrow transplantation

KW - JAK2 V617F mutation

KW - Molecular remission

KW - Myelofibrosis with myeloid metaplasia

UR - http://www.scopus.com/inward/record.url?scp=34247487437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247487437&partnerID=8YFLogxK

U2 - 10.1002/ajh.20832

DO - 10.1002/ajh.20832

M3 - Article

C2 - 17133423

AN - SCOPUS:34247487437

VL - 82

SP - 400

EP - 402

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 5

ER -